| Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors RL Flynn, KE Cox, M Jeitany, H Wakimoto, AR Bryll, NJ Ganem, F Bersani, ... Science 347 (6219), 273-277, 2015 | 521 | 2015 |
| Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression Y Jiang, YY Jiang, JJ Xie, A Mayakonda, M Hazawa, L Chen, JF Xiao, ... Nature communications 9 (1), 3619, 2018 | 188 | 2018 |
| TP63, SOX2, and KLF5 establish a core regulatory circuitry that controls epigenetic and transcription patterns in esophageal squamous cell carcinoma cell lines YY Jiang, Y Jiang, CQ Li, Y Zhang, P Dakle, H Kaur, JW Deng, RYT Lin, ... Gastroenterology 159 (4), 1311-1327. e19, 2020 | 107 | 2020 |
| Inhibition of DDR 1‐BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer M Jeitany, C Leroy, P Tosti, M Lafitte, J Le Guet, V Simon, D Bonenfant, ... EMBO molecular medicine 10 (4), e7918, 2018 | 96 | 2018 |
| A preclinical mouse model of glioma with an alternative mechanism of telomere maintenance (ALT) M Jeitany, JR Pineda, Q Liu, RM Porreca, F Hoffschir, C Desmaze, ... International Journal of Cancer 136 (7), 1546-1558, 2015 | 33 | 2015 |
| Opposite effects of GCN5 and PCAF knockdowns on the alternative mechanism of telomere maintenance M Jeitany, D Bakhos-Douaihy, DC Silvestre, JR Pineda, N Ugolin, ... Oncotarget 8 (16), 26269, 2017 | 19 | 2017 |
| ZRSR1 co-operates with ZRSR2 in regulating splicing of U12-type introns in murine hematopoietic cells V Madan, Z Cao, WW Teoh, P Dakle, L Han, P Shyamsunder, M Jeitany, ... Haematologica 107 (3), 680, 2022 | 13 | 2022 |
| Novel carfilzomib-based combinations as potential therapeutic strategies for liposarcomas M Jeitany, A Prabhu, P Dakle, E Pathak, V Madan, D Kanojia, ... Cellular and Molecular Life Sciences 78, 1837-1851, 2021 | 8 | 2021 |
| Intranasal administration of temozolomide delayed the development of brain tumors initiated by human glioma stem-like cell in nude mice JR Pineda, M Jeitany, A Andrieux, MP Junier, H Chneiweiss, FD Boussin Cancer Sci. Ther 9, 374-378, 2017 | 8 | 2017 |
| ALT cancer cells are specifically sensitive to lysine acetyl transferase inhibition D Bakhos-Douaihy, C Desmaze, M Jeitany, LR Gauthier, D Biard, ... Oncotarget 10 (7), 773, 2019 | 6 | 2019 |
| Signalling inhibition by ponatinib disrupts productive alternative lengthening of telomeres (ALT) FK Kusuma, A Prabhu, G Tieo, SM Ahmed, P Dakle, WK Yong, E Pathak, ... Nature Communications 14 (1), 1919, 2023 | 4 | 2023 |
| ChIP-MS reveals the local chromatin composition by label-free quantitative proteomics WK Yong, G Rane, N Zaal Anuar, X Shao, CY Goh, V Khanchandani, ... bioRxiv, 2023.01. 27.525999, 2023 | 2 | 2023 |
| TP63, SOX2 and KLF5 establish core regulatory circuitry and construct cancer specific epigenome in esophageal squamous cell carcinoma YY Jiang, Y Jiang, CQ Li, Y Zhang, P Dakle, H Kaur, JW Deng, RYT Lin, ... bioRxiv, 825372, 2019 | 2 | 2019 |
| Abstract LT07: Signalling Inhibition by Ponatinib Disrupts Productive Alternative Lengthening of Telomeres (ALT) F Kusuma, A Prabhu, G Tieo, SM Ahmad, P Dakle, WK Yong, E Pathak, ... Cancer Research 84 (8_Supplement), LT07-LT07, 2024 | | 2024 |
| 103P Using AI to break new ground in oncological drug discovery: Rapid identification of novel targets and polypharmacological compounds for effective liposarcoma treatment N Subramanian, N Maignan, G Tieo, D Papazian, J Dawe, M Georges, ... ESMO Open 9, 2024 | | 2024 |
| The oncogenic role of the collagen receptor DDRI and the pseudokinase Pragmin in metastatic colorectal cancer C Lecointre, M Jeitany, C Leroy, P Tosti, V Simon, F Allemand, A Foumet, ... INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 40, S18-S18, 2017 | | 2017 |
| The anti-leukemic drug nilotinib inhibits metastatic properties of colorectal cancer cells by targeting the receptor tyrosine kinase DDR1 P Tosti, C Leroy, M Jeitany, V Simon, D Bonenfant, L Thouennon, ... European Journal of Cancer 1 (61), S148-S149, 2016 | | 2016 |
| Proteomic comparison of ALT and Telomerase+ Glioma Stem cells F Chevalier, D Silvestre, M Jeitany, J Depagne, P Bertrand, JM Studler, ... HUPO 2011 10th World Congress, 2011 | | 2011 |
